List Labs Technical Support

All users must log in to gain access to create a support ticket for technical assistance and track all cases. If you are new to our site, please create an account.

Intrarectal Instillation of Clostridium difficile Toxin A Triggers Colonic Inflammation and Tissue Damage: Development of a Novel and Efficient Mouse Model of Clostridium difficile Toxin Exposure

Last Updated: Aug 30, 2018 01:28PM PDT
​"We are using purified TcdA and TcdB from List Biological Laboratories Inc. in an effort to discover novel drugs for treating recurring C. difficile infections in humans. To this end, the toxins are admixed with drug candidates and instilled intra-rectally into the colons of mice as described in Hirota, S. et al. (ref). Drug efficacy is then determined by the reduction in intestinal inflammatory markers relative to untreated control animals."  "List Labs purified toxins performed well in our assays." 
 
Glen D Armstrong
Professor and Former Head
Microbiology, Immunology, and Infectious Diseases
Cumming School of Medicine
University of Calgary

For more information about our C. difficile​ products,
please visit us at: 
https://www.listlabs.com/products/difficile-toxins/​

If you have additional inquiries, please feel free to continue your search in our Knowledge Base
or contact us with your question by submitting a support ticket here:  https://listlabsinc.desk.com/customer/login?return_to=%2F
0ffdb7e3300fe954e7f9f4ebfe1031f7@listlabsinc.desk-mail.com
https://cdn.desk.com/
false
desk
Loading
seconds ago
a minute ago
minutes ago
an hour ago
hours ago
a day ago
days ago
about
false
Invalid characters found
/customer/en/portal/articles/autocomplete